Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash

Quest Diagnostics, carrying a Zacks Rank #2, reported a second-quarter adjusted EPS of $2.35, which surpassed the Zacks Consensus Estimate by 1.7$2.40 billion exceeded the Zacks Consensus Estimate by 0.5%. DGX's historical five-year earnings growth rate of 7.4% compares favorably with the industry's 4.2%. The company surpassed earnings estimates in each of the trailing four quarters, the average being 3.31%. Edwards Lifesciences Corporation (EW) reported adjusted earnings per share (EPS) of 7 ...